Plenty of researches have shown that the concentration of B2M in serum or urine raised in diverse diseases, such as breast cancer, prostate cancer, lung cancer, renal cancer, multiple myeloma, and especially non-Hodgkin's lymphoma42–47. The gene discussed is B2M; the disease is lung cancer.